Skip to main content

Table 2 Patient Global Impression of Change at final assessment

From: A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia

  Placebo Pregabalin
Number assesseda 247 249
Very much improved 16 (6.5)b 31 (12.4)
Much improved 50 (20.2) 65 (26.1)
Minimally improved 88 (35.6) 79 (31.7)
No change 60 (24.3) 43 (17.3)
Minimally worse 14 (5.7) 14 (5.6)
Much worse 13 (5.3) 13 (5.2)
Very much worse 6 (2.4) 4 (1.6)
P-valuec 0.0078
  1. aNumber of patients with available data for this analysis. bNumber (%) of patients. cBased on chi-square test with a modified rigid transformation.